[1]
“Role of antibodies against PAR-1 and PAR-2 in cancer in the kidney transplant recipients”, Adv. RAB Res., vol. 1, no. 1, p. Advances in RAB Research, Vol 1, No 1, 2018 –, Sep. 2018, doi: 10.18416/RAB.2018.1809014.